Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction

被引:0
|
作者
Rodney A. Appell
机构
关键词
Urinary Retention; Lower Urinary Tract Symptom; Overactive Bladder; Detrusor Overactivity; Tolterodine;
D O I
10.1007/s11934-006-0015-z
中图分类号
学科分类号
摘要
引用
收藏
页码:429 / 429
相关论文
共 50 条
  • [1] Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction
    Abrams, P
    Kaplan, S
    Gans, HJD
    Millard, R
    JOURNAL OF UROLOGY, 2006, 175 (03) : 999 - 1004
  • [2] Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder
    Lee, JY
    Kim, HW
    Lee, SJ
    Koh, JS
    Suh, HJ
    Chancellor, MB
    BJU INTERNATIONAL, 2004, 94 (06) : 817 - 820
  • [3] Overactive bladder and outlet obstruction in men
    Chung D.E.
    Sandhu J.S.
    Current Urology Reports, 2011, 12 (1) : 77 - 85
  • [4] Tolterodine for the treatment of overactive bladder
    Salvatore, Stefano
    Serati, Maurizio
    Bolis, Pierfrancesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (07) : 1249 - 1255
  • [5] Management of Overactive Bladder After Treatment of Bladder Outlet Obstruction
    Ellis, Jeffrey L.
    Braun, Avery E.
    Cohn, Joshua A.
    CURRENT BLADDER DYSFUNCTION REPORTS, 2019, 14 (03) : 197 - 204
  • [6] Management of Overactive Bladder After Treatment of Bladder Outlet Obstruction
    Jeffrey L. Ellis
    Avery E. Braun
    Joshua A. Cohn
    Current Bladder Dysfunction Reports, 2019, 14 : 197 - 204
  • [7] Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine
    R. A. Appell
    P. Abrams
    H. P. Drutz
    P. E. V. A. Van Kerrebroeck
    R. Millard
    A. Wein
    World Journal of Urology, 2001, 19 : 141 - 147
  • [8] Tolterodine for the treatment of overactive bladder: a review
    Rovner, ES
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (04) : 653 - 666
  • [9] Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder
    Kreder, K
    Mayne, C
    Jonas, U
    EUROPEAN UROLOGY, 2002, 41 (06) : 588 - 595
  • [10] Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder
    Raes, A
    Hoebeke, P
    Segaert, I
    Van Laecke, E
    Dehoorne, J
    Vande Walle, J
    EUROPEAN UROLOGY, 2004, 45 (02) : 240 - 244